Angelova, P.R.; Andruska, K.M.; Midei, M.G.; Barilani, M.; Atwal, P.; Tucher, O.; Milner, P.; Heerinckx, F.; Shchepinov, M.S.
RT001 in Progressive Supranuclear Palsy—Clinical and In-Vitro Observations. Antioxidants 2021, 10, 1021.
https://doi.org/10.3390/antiox10071021
AMA Style
Angelova PR, Andruska KM, Midei MG, Barilani M, Atwal P, Tucher O, Milner P, Heerinckx F, Shchepinov MS.
RT001 in Progressive Supranuclear Palsy—Clinical and In-Vitro Observations. Antioxidants. 2021; 10(7):1021.
https://doi.org/10.3390/antiox10071021
Chicago/Turabian Style
Angelova, Plamena R., Kristin M. Andruska, Mark G. Midei, Mario Barilani, Paldeep Atwal, Oliver Tucher, Peter Milner, Frederic Heerinckx, and Mikhail S. Shchepinov.
2021. "RT001 in Progressive Supranuclear Palsy—Clinical and In-Vitro Observations" Antioxidants 10, no. 7: 1021.
https://doi.org/10.3390/antiox10071021
APA Style
Angelova, P. R., Andruska, K. M., Midei, M. G., Barilani, M., Atwal, P., Tucher, O., Milner, P., Heerinckx, F., & Shchepinov, M. S.
(2021). RT001 in Progressive Supranuclear Palsy—Clinical and In-Vitro Observations. Antioxidants, 10(7), 1021.
https://doi.org/10.3390/antiox10071021